All Pathways
Cardiothoracic SurgeryManagement

Temporary Mechanical Circulatory Support (EACTS/STS/AATS 2025)

Temporary Mechanical Circulatory Support (EACTS/STS/AATS 2025): Postcardiotomy Cardiogenic Shock → Initial Assessment → Shock Severity? → IABP (Intra-Ao...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Postcardiotomy Cardiogenic Shock

    Failure to wean from CPB or post-op hemodynamic deterioration

    1. Action

      Initial Assessment

      Evaluate severity and optimize medical therapy

      • Confirm adequate surgical repair
      • Optimize preload (CVP, PCWP)
      • Optimize afterload (MAP, SVR)
      • Maximize inotropes: dobutamine, milrinone, epinephrine
      • Consider echo to assess function
      • Rule out tamponade, graft failure
      1. Decision

        Shock Severity?

        Assess level of hemodynamic support needed

        • MODERATE: CI 1.8-2.2, lactate 2-4, single inotrope
        • SEVERE: CI <1.8, lactate >4, multiple inotropes
        • REFRACTORY: worsening despite maximum support
        1. Action

          IABP (Intra-Aortic Balloon Pump)

          First-line for moderate support

          • INDICATIONS:
          • • Moderate shock
          • • Ischemic cardiomyopathy
          • • Bridge during optimization
          • CONTRAINDICATIONS:
          • • Severe aortic regurgitation
          • • Aortic dissection
          • • Severe PAD
          • Provides 10-15% increase in CO
          • Reduces afterload, augments diastolic pressure
          1. Action

            Ongoing Management

            Monitor and optimize on support

            • Daily echo to assess recovery
            • Lactate clearance
            • End-organ function (renal, hepatic)
            • Anticoagulation (target ACT/aPTT)
            • Hemolysis monitoring (LDH, plasma-free Hb)
            • Limb perfusion (distal perfusion catheter for femoral)
            1. Decision

              Weaning Assessment

              Daily evaluation for recovery

              • Criteria for weaning trial:
              • • Improving echo (EF, contractility)
              • • Lactate <2 mmol/L
              • • Stable on low/no inotropes
              • • Adequate MAP at reduced flow
              • • Improving end-organ function
              1. Outcome

                Myocardial Recovery

                Wean and decannulate

              2. Decision

                No Recovery - Bridge Options?

                Consider advanced therapies

                • Bridge to transplant (BTT)
                • Bridge to durable LVAD
                • Bridge to decision (BTD)
                • Palliation/withdrawal if no options
        2. Action

          Impella (Percutaneous LVAD)

          For LV-predominant failure

          • INDICATIONS:
          • • Severe LV dysfunction, CI <1.8
          • • Need for LV unloading
          • • High-risk PCI support
          • DEVICES:
          • • CP: up to 4.3 L/min
          • • 5.0/5.5: up to 5+ L/min (surgical)
          • CONTRAINDICATIONS:
          • • Mechanical aortic valve
          • • LV thrombus
          • • Severe AS
          • • Severe PAD
        3. Action

          VA-ECMO / ECLS

          For biventricular or refractory failure

          • INDICATIONS:
          • • Biventricular failure
          • • Refractory cardiogenic shock
          • • Cardiac arrest (E-CPR)
          • • Failure of other devices
          • • Need for respiratory support
          • Provides 3-7 L/min full circulatory support
          • CONFIGURATION:
          • • Peripheral (femoral) or central cannulation
          • • Consider LV vent if no ejection
          1. Action

            LV Unloading Strategy

            Required if no LV ejection on VA-ECMO

            • Options:
            • • IABP (augments coronary flow)
            • • Impella (active LV drain)
            • • Surgical LV vent
            • • Atrial septostomy
            • Prevents LV distension and pulmonary edema
      2. Warning

        ⚠️ Rule Out First

        Before MCS, ensure: adequate surgical repair, no tamponade, no graft occlusion, no protamine reaction

Guideline Source

EACTS/STS/AATS Guidelines on Temporary MCS in Adult Cardiac Surgery

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Device availability varies by institution
  • Requires specialized team for insertion and management
  • Specific device selection depends on local expertise
  • Does not replace clinical judgment for complex cases

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Temporary Mechanical Circulatory Support (EACTS/STS/AATS 2025)?

The Temporary Mechanical Circulatory Support (EACTS/STS/AATS 2025) is a management clinical algorithm for Cardiothoracic Surgery. It provides a structured decision tree to guide clinical decision-making, based on EACTS/STS/AATS Guidelines on Temporary MCS in Adult Cardiac Surgery.

What guideline is the Temporary Mechanical Circulatory Support (EACTS/STS/AATS 2025) based on?

This algorithm is based on EACTS/STS/AATS Guidelines on Temporary MCS in Adult Cardiac Surgery (DOI: 10.1093/ejcts/ezaf330).

What are the limitations of the Temporary Mechanical Circulatory Support (EACTS/STS/AATS 2025)?

Known limitations include: Device availability varies by institution; Requires specialized team for insertion and management; Specific device selection depends on local expertise; Does not replace clinical judgment for complex cases. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Temporary Mechanical Circulatory Support (EACTS/STS/AATS 2025) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free